MOPEAD Policy Recommendations and Public Awareness Strategy now available!

Two key MOPEAD project deliverables were released at a lunch debate co-organised by Alzheimer Europe, MOPEAD, AMYPAD and Act on Dementia (the 2nd EU Joint Action on Dementia) in Brussels on 10 December 2019. The event looked at improving the diagnosis of dementia and explored the findings from European research collaborations. As part of this, MOPEAD distributed our Recommendations for Policy Makers and Regulators, and our Public Education/Awareness Strategies.

 

Sirpa Pietikäinen, Member of the European Parliament opened the event. Presentations were made by Pierre Krolak-Salmon (Institut du Vieillissement, Lyon, France) who presented Act on Dementia graduated diagnosis strategy, Mercè Boada (Fundacio ACE and MOPEAD Coordinator) who presented MOPEAD’s results on the effectiveness of the models of patient engagement tested and evaluated by MOPEAD, and Gill Farrar (GE Healthcare and AMYPAD Partner) who talked about the role of Imaging in the diagnosis and prognosis of AD.

 

Follow all MOPEAD news on our Twitter @MopeadEU and stay up to date with all our deliverables on our website here.

 

Share on Facebook
Share on Twitter
Please reload

Please reload

Archive
Please reload

Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

©2019 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations